Banerji, Udai ;
Dean, Emma J ;
Alejandro Perez-Fidalgo, J...
Banerji , U , Dean , E J , Alejandro Perez-Fidalgo , J , Batist , G , Bedard , P L , You , B , Westin , S N , Kabos , P , Garrett , M D , Tall , M , Ambrose , H , Carl Barrett , J , Hedley Carr , T , Amy Cheung , S Y , Corcoran , C , Cullberg , M , Davies , B R , de Bruin , E C , Elvin , P , Foxley , A , Lawrence , P , Lindemann , J P O , Maudsley , R , Pass , M , Rowlands , V , Rugman , P , Schiavon , G , Yates , J & Schellens , J H M 2018 , ' A phase i open-label study to identify a dosing regimen of the pan-akt inhibitor azd5363 for evaluation in solid tumors and in pik3ca-mutated breast and gynecologic cancers ' , Clinical Cancer Research , vol. 24 , no. 9 , pp. 2050-2059 . https://doi.org/10.1158/1078-0432.CCR-17-2260.
,
2018
